Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599215 · ClinicalTrials.gov registry record · NA
A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration
A NA study, sponsored by Baystate Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT07599215 is a NA study that has completed, run by Baystate Medical Center. The registered enrollment target is 56 participants.
The verdict
NCT07599215, a NA study, has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. behaviors, and 2) time away from the primary task. Secondary outcomes included 1) medication administration errors and 2) perceived workload as measured by the NASA Task Load Index.
Interventions
- OTHER Experimental: Stay S.A.F.E. Interruption Management Education
- OTHER Medication Safety Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07599215
The ClinicalTrials.gov registry entry for NCT07599215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baystate Medical Center, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental: Stay S.A.F.E. Interruption Management Education is the first listed.
NCT07599215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07599215 about?
NCT07599215 is a clinical study titled "A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration". The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. b...
What is the current status of trial NCT07599215?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2024-05-13. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT07599215?
The interventions under investigation include: Experimental: Stay S.A.F.E. Interruption Management Education (OTHER), Medication Safety Education (OTHER).
Who is sponsoring clinical trial NCT07599215?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.